Innervation of dystrophic muscle after muscle stem cell therapy

Muscle Nerve. 2016 Oct;54(4):763-8. doi: 10.1002/mus.25115. Epub 2016 Aug 17.

Abstract

Introduction: Duchenne muscular dystrophy (DMD) is caused by loss of the structural protein, dystrophin, resulting in muscle fragility. Muscle stem cell (MuSC) transplantation is a potential therapy for DMD. It is unknown whether donor-derived muscle fibers are structurally innervated.

Methods: Green fluorescent protein (GFP)-expressing MuSCs were transplanted into the tibials anterior of adult dystrophic mdx/mTR mice. Three weeks later the neuromuscular junction was labeled by immunohistochemistry.

Results: The percent overlap between pre- and postsynaptic immunolabeling was greater in donor-derived GFP(+) myofibers, and fewer GFP(+) myofibers were identified as denervated compared with control GFP(-) fibers (P = 0.001 and 0.03). GFP(+) fibers also demonstrated acetylcholine receptor fragmentation and expanded endplate area, indicators of muscle reinnervation (P = 0.008 and 0.033).

Conclusion: It is unclear whether GFP(+) fibers are a result of de novo synthesis or fusion with damaged endogenous fibers. Either way, donor-derived fibers demonstrate clear histological innervation. Muscle Nerve 54: 763-768, 2016.

Keywords: Duchenne muscular dystrophy; denervation; muscle stem cell; neuromuscular junction; skeletal muscle.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Mice
  • Mice, Inbred mdx
  • Mice, Transgenic
  • Muscle Cells / chemistry
  • Muscle Cells / transplantation*
  • Muscle Fibers, Skeletal / chemistry
  • Muscle Fibers, Skeletal / transplantation
  • Muscle, Skeletal / chemistry
  • Muscle, Skeletal / innervation*
  • Muscular Dystrophy, Animal / physiopathology
  • Muscular Dystrophy, Animal / therapy
  • Muscular Dystrophy, Duchenne / physiopathology*
  • Muscular Dystrophy, Duchenne / therapy*
  • Stem Cell Transplantation / methods*